‡ In these countries please contact our distributor

Roland Diggelmann

Appointed Independent Non-Executive Director and Member of the Audit Committee on 1 March 2018 until 21 October 2019, when the Company announced Roland would be appointed Chief Executive Officer with effect from 1 November 2019.  He was elected by shareholders at the Annual General Meeting (AGM) on 12 April 2018 and will stand for re-election as Chief Executive Officer at the AGM on 9 April 2020. 

Roland is based in Zug, Switzerland.

 Adobe Acrobat PDF icon The Role of the Chief Executive Officer 

Career and Experience

Roland studied Business Administration at the University of Berne. In 1995, he joined Sulzer Medica AG as Manager Strategic Planning and progressed into further senior roles over the years until his appointment as Executive Vice President, Sales Europe and Asia Pacific from 2002 to 2004 for Sulzer Medica AG (later known as Centerpulse).

Roland joined Zimmer Group in 2004, in the role of Managing Director of Zimmer Japan and then later in 2006 as Senior Vice President, EMEA until 2008. Roland joined Roche Diagnostics in 2008 starting as president of Asia Pacific before assuming the role of Chief Executive Officer of the Diagnostics Division of F. Hoffmann-La Roche Ltd from 2012 until September 2018.

Other Current Appointments

  • Director of Igenomix.
  • Director of HeartForce AG. 
  • Director of Accelerate Diagnostics, Inc., which is listed on NASDAQ (Nasdaq: AXDX). 

Skills and Competencies

Having spent his whole career in medical devices, with 12 years at Sulzer and Zimmer, Roland brings an in-depth knowledge of the medical device industry and healthcare environment, which is of great value to Smith+Nephew.